Trade Siemens Healthineers AG - SHL CFD

Add to favourite

50.530

0.79%

0.220

Low: 49.825

High: 50.53

Market Trading Hours* (UTC) Open now
Closes on Friday at 15:30

Mon - Fri: 07:00 - 15:30

Summary
Historical Data
Events
Income Statement
Balance Sheet
Cash Flow

Trading сonditions

Spread

0.220

Long position overnight fee

-0.022102%

Short position overnight fee

-0.000121%

Overnight fee time

21:00 (UTC)

Min traded quantity

Currency

EUR

Margin

Stock exchange

Germany

Commission on trade

*Information provided by Capital.com

Siemens Healthineers AG ESG Risk Ratings

High Medium Low Negligible

‘A’ score indicates excellent relative ESG performance and high degree of transparency in reporting material ESG data publicly

More ESG coverage

Key Stats

Prev. Close*	50.93
Open*	49.825
1-Year Change*	-6.98%
Day's Range*	49.825 - 50.53
52 wk Range	40.32-67.66
Average Volume (10 days)	754.78K
Average Volume (3 months)	15.57M
Market Cap	57.35B
P/E Ratio	30.63
Shares Outstanding	1.12B
Revenue	20.88B
EPS	1.66
Dividend (Yield %)	1.67191
Beta	0.53
Next Earnings Date	Feb 1, 2023

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

Last Week
Last Month
Last Year
Last two Years
Max

Daily
Weekly
Monthly

Date	Close	Change	Change (%)	Open	High	Low
Apr 18, 2024	50.930	-1.080	-2.08%	52.010	52.030	50.870
Apr 17, 2024	51.970	-0.260	-0.50%	52.230	52.550	51.930
Apr 16, 2024	52.730	0.540	1.03%	52.190	53.065	52.170
Apr 15, 2024	53.405	0.300	0.56%	53.105	53.985	53.105
Apr 12, 2024	53.205	-0.920	-1.70%	54.125	54.565	53.065
Apr 11, 2024	53.925	-0.560	-1.03%	54.485	54.525	53.565
Apr 10, 2024	54.825	0.200	0.37%	54.625	55.325	54.405
Apr 9, 2024	54.525	-0.460	-0.84%	54.985	55.125	53.845
Apr 8, 2024	55.625	0.080	0.14%	55.545	55.705	54.765
Apr 5, 2024	55.445	0.660	1.20%	54.785	55.485	54.665
Apr 4, 2024	55.645	0.240	0.43%	55.405	55.685	54.645
Apr 3, 2024	55.525	-0.200	-0.36%	55.725	56.045	55.225
Apr 2, 2024	55.825	-0.375	-0.67%	56.200	56.380	54.965
Mar 28, 2024	56.560	0.380	0.68%	56.180	56.840	56.140
Mar 27, 2024	56.160	1.575	2.89%	54.585	56.320	54.585
Mar 26, 2024	55.205	0.420	0.77%	54.785	55.565	54.785
Mar 25, 2024	55.205	0.880	1.62%	54.325	55.405	54.325
Mar 22, 2024	55.165	1.060	1.96%	54.105	55.285	54.105
Mar 21, 2024	55.205	-0.080	-0.14%	55.285	55.645	54.685
Mar 20, 2024	54.845	-0.980	-1.76%	55.825	55.865	54.465

Siemens Healthineers AG Events

Time (UTC)	Country	Event
Friday, April 19, 2024
Time (UTC) 12:00	Country DE	Event Siemens Healthineers AG Siemens Healthineers AG Forecast - Previous -
Time (UTC) 12:00	Country DE	Event Siemens Healthineers AG Siemens Healthineers AG Forecast - Previous -
Tuesday, May 7, 2024
Time (UTC) 10:59	Country DE	Event Q2 2024 Siemens Healthineers AG Earnings Call Q2 2024 Siemens Healthineers AG Earnings Call Forecast - Previous -
Time (UTC) 10:59	Country DE	Event Q2 2024 Siemens Healthineers AG Earnings Release Q2 2024 Siemens Healthineers AG Earnings Release Forecast - Previous -
Wednesday, May 8, 2024
Time (UTC) 10:59	Country DE	Event Siemens Healthineers AG Roadshow Siemens Healthineers AG Roadshow Forecast - Previous -
Monday, May 13, 2024
Time (UTC) 10:59	Country DE	Event Siemens Healthineers AG Roadshow Siemens Healthineers AG Roadshow Forecast - Previous -
Wednesday, July 31, 2024
Time (UTC) 10:59	Country DE	Event Q3 2024 Siemens Healthineers AG Earnings Call Q3 2024 Siemens Healthineers AG Earnings Call Forecast - Previous -

View all events

Annual
Quarterly

	2022	2021	2020	2019	2018
Total revenue	21714	17997	14460	14518	13429
Revenue	21714	17997	14460	14518	13429
Cost of Revenue, Total	13577	11045	8880	8722	7961
Gross Profit	8137	6952	5580	5796	5468
Total Operating Expense	18787	15424	12478	12222	11468
Selling/General/Admin. Expenses, Total	3408	2817	2279	2214	2153
Research & Development	1785	1546	1342	1328	1281
Other Operating Expenses, Total	19	32	11	-42	92
Operating Income	2927	2573	1982	2296	1961
Interest Income (Expense), Net Non-Operating	-70	-50	-20	-82	-157
Other, Net	-57	-119	-8	-21	-5
Net Income Before Taxes	2800	2404	1954	2193	1799
Net Income After Taxes	2054	1746	1422	1586	1284
Minority Interest	-17	-18	-12	-18	-19
Net Income Before Extra. Items	2037	1728	1410	1568	1265
Net Income	2037	1728	1410	1568	1265
Income Available to Common Excl. Extra. Items	2038	1726	1411	1567	1265
Income Available to Common Incl. Extra. Items	2038	1726	1411	1567	1265
Diluted Net Income	2038	1726	1411	1567	1265
Diluted Weighted Average Shares	1127.75	1100	1004.07	1000.14	1000.06
Diluted EPS Excluding Extraordinary Items	1.80714	1.56909	1.40528	1.56678	1.26492
Diluted Normalized EPS	1.88455	1.68596	1.43935	1.608	1.39339
Unusual Expense (Income)		-11	-34		-19
Dividends per Share - Common Stock Primary Issue	0.95	0.85	0.8	0.8	0.39843
Total Adjustments to Net Income	1	-2	1	-1
Interest Expense (Income) - Net Operating	-2	-5

	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022
Total revenue	5201	5346	5077	6000	5186
Revenue	5201	5346	5077	6000	5186
Cost of Revenue, Total	3265	3723	3220	3678	3317
Gross Profit	1936	1623	1857	2322	1869
Total Operating Expense	4633	5157	4557	5120	4591
Selling/General/Admin. Expenses, Total	881	902	882	939	840
Research & Development	474	465	441	497	436
Interest Expense (Income) - Net Operating	0	-2	-1	-1	2
Other Operating Expenses, Total	13	69	15	7	-4
Operating Income	568	189	520	880	595
Interest Income (Expense), Net Non-Operating	-63	-45	-26	-23	-18
Other, Net	11	-2	1	2	-51
Net Income Before Taxes	516	142	495	859	526
Net Income After Taxes	451	109	425	635	364
Minority Interest	-6	-4	-4	-5	-1
Net Income Before Extra. Items	445	105	421	630	363
Net Income	445	105	421	630	363
Income Available to Common Excl. Extra. Items	445	105	421	631	363
Income Available to Common Incl. Extra. Items	445	105	421	631	363
Diluted Net Income	445	105	421	631	363
Diluted Weighted Average Shares	1112.5	1141.3	1137.84	1134.18	1134.38
Diluted EPS Excluding Extraordinary Items	0.4	0.092	0.37	0.55635	0.32
Dividends per Share - Common Stock Primary Issue	0	0	0	0.95	0
Diluted Normalized EPS	0.38507	0.13437	0.38434	0.57655	0.33403
Total Adjustments to Net Income		0	0	1

Annual
Quarterly

	2023	2022	2021	2020	2019
Total Current Assets	14136	13379	10782	10268	7779
Cash and Short Term Investments	2191	1666	1462	771	976
Cash & Equivalents	1642	1436	1322	656	920
Short Term Investments	549	230	140	115	56
Total Receivables, Net	7005	6996	5951	7053	4649
Accounts Receivable - Trade, Net	6121	5699	4856	3386	3618
Total Inventory	4294	4009	3179	2304	2064
Other Current Assets, Total	646	521	55	55	34
Total Assets	46684	49056	41927	25094	21429
Property/Plant/Equipment, Total - Net	4210	4273	3712	2774	2318
Goodwill, Net	18118	19061	17456	9038	8590
Intangibles, Net	7726	8712	8074	1912	1576
Long Term Investments	1596	294	256	135	133
Note Receivable - Long Term	2	257	212	162	144
Other Long Term Assets, Total	896	3080	1435	805	889
Total Current Liabilities	13440	12024	10113	7289	5605
Accounts Payable	2203	2315	1921	1356	1403
Notes Payable/Short Term Debt		0	0	0	0
Current Port. of LT Debt/Capital Leases	4402	2851	2157	2213	444
Other Current Liabilities, Total	6835	5578	4513	2857	2861
Total Liabilities	28603	29220	25890	12596	11660
Total Long Term Debt	12258	13811	12165	3296	4092
Long Term Debt	12258	13343	11684	2972	4070
Capital Lease Obligations		468	481	324	22
Deferred Income Tax	1663	2110	2082	470	375
Minority Interest	52	16	18	13	13
Other Liabilities, Total	1190	1259	1512	1528	1575
Total Equity	18081	19836	16037	12498	9769
Common Stock	1128	1128	1128	1075	1000
Retained Earnings (Accumulated Deficit)	1381	894	-300	-1276	-1859
Other Equity, Total	340	2388	-340	-708	-116
Total Liabilities & Shareholders’ Equity	46684	49056	41927	25094	21429
Total Common Shares Outstanding	1121.49	1119.39	1122.67	1074.1	999.349
Treasury Stock - Common	-607	-405	-240	-36	-24
Prepaid Expenses		187	135	85	56
Property/Plant/Equipment, Total - Gross		8392	7364	6033	5357
Accumulated Depreciation, Total		-4119	-3651	-3257	-3039
Accrued Expenses		1280	1522	863	897
Additional Paid-In Capital	15839	15861	15818	13476	10801
Unrealized Gain (Loss)		-30	-29	-33	-33

	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022
Total Current Assets	14136	13703	13027	13544	13379
Cash and Short Term Investments	2191	2384	1751	1916	2160
Cash & Equivalents	1642	1779	1370	1352	1436
Short Term Investments	549	605	381	564	724
Total Receivables, Net	7005	6297	6407	6804	6591
Accounts Receivable - Trade, Net	6121	5460	5380	5441	5699
Total Inventory	4294	4387	4221	4216	4009
Other Current Assets, Total	646	635	648	608	619
Total Assets	46684	45518	45312	46613	49056
Property/Plant/Equipment, Total - Net	4210	4089	4090	4134	4273
Goodwill, Net	18118	17786	17859	18083	19061
Intangibles, Net	7726	7520	7574	8050	8712
Long Term Investments	1596	1498	1815	1851	2609
Other Long Term Assets, Total	896	920	944	947	1020
Total Current Liabilities	13440	14113	13749	11911	12024
Accounts Payable	2203	2060	2113	2104	2315
Notes Payable/Short Term Debt		0	0	0	0
Current Port. of LT Debt/Capital Leases	4402	5630	5234	3251	2851
Other Current Liabilities, Total	6835	6423	6402	6556	6858
Total Liabilities	28603	28331	27975	28028	29220
Total Long Term Debt	12258	11117	11103	12886	13811
Long Term Debt	12258	11117	11103	12886	13811
Capital Lease Obligations
Deferred Income Tax	1663	1672	1729	1897	2110
Minority Interest	52	15	10	14	16
Other Liabilities, Total	1190	1414	1384	1320	1259
Total Equity	18081	17187	17337	18585	19836
Common Stock	1128	1128	1128	1128	1128
Retained Earnings (Accumulated Deficit)	1381	801	405	1340	894
Treasury Stock - Common	-607	-567	-270	-300	-405
Other Equity, Total	340	18	293	636	2358
Total Liabilities & Shareholders’ Equity	46684	45518	45312	46613	49056
Total Common Shares Outstanding	1121.49	1122.22	1122.22	1119.39	1119.39
Additional Paid-In Capital	15839	15807	15781	15781	15861
Note Receivable - Long Term	2	2	3	4	2

Annual
Quarterly

	2022	2021	2020	2019	2018
Net income/Starting Line	2054	1746	1423	1586	1284
Cash From Operating Activities	2504	2933	1928	1616	1595
Cash From Operating Activities	1343	1039	815	620	530
Non-Cash Items	1000	798	639	610	543
Cash Taxes Paid	877	808	512	493	266
Cash Interest Paid	248	150	123	119	155
Changes in Working Capital	-1893	-650	-949	-1200	-762
Cash From Investing Activities	-868	-14140	-1912	-647	-743
Capital Expenditures	-852	-674	-557	-579	-530
Other Investing Cash Flow Items, Total	-16	-13466	-1355	-68	-213
Cash From Financing Activities	-1644	11839	-249	-603	-489
Financing Cash Flow Items	-212	10794	-1992	95	575
Issuance (Retirement) of Debt, Net	-169	-155	-101	52	-1
Foreign Exchange Effects	122	34	-31	35	-28
Net Change in Cash	114	666	-264	401	335
Total Cash Dividends Paid	-955	-856	-798	-699	-1008
Issuance (Retirement) of Stock, Net	-308	2056	2642	-51	-55

	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022
Net income/Starting Line	534	426	2054	1419	1055
Cash From Operating Activities	844	123	2504	1766	1101
Cash From Operating Activities	916	334	1343	1011	669
Non-Cash Items	44	-64	1000	692	420
Cash Taxes Paid	417	160	877	660	370
Cash Interest Paid	134	35	248	143	116
Changes in Working Capital	-650	-573	-1893	-1356	-1043
Cash From Investing Activities	-402	-202	-868	-583	-383
Capital Expenditures	-405	-200	-852	-568	-382
Other Investing Cash Flow Items, Total	3	-2	-16	-15	-1
Cash From Financing Activities	-396	77	-1644	-1228	-1022
Financing Cash Flow Items	854	177	-212	-61	97
Total Cash Dividends Paid	-1066		-955	-955	-955
Issuance (Retirement) of Stock, Net	-56	-27	-308	-86	-83
Issuance (Retirement) of Debt, Net	-128	-73	-169	-126	-81
Foreign Exchange Effects	-112	-81	122	96	58
Net Change in Cash	-66	-83	114	51	-246

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission

Leverage

1:1

20
100
500
1000
10000

Investment

Trade size (Leverage x Investement):

Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Siemens Healthineers AG Company profile

About Siemens Healthineers AG

Siemens Healthineers AG is a Germany-based company that supplies technology to the healthcare industry. The Company offers a wide range of products and services in the fields of diagnostic and therapeutic imaging, laboratory and point of care diagnostics, and molecular medicine. It provides medical technology and software solutions, as well as clinical consulting services. Additionally, the Company develops its digital health and enterprise services trough expanding precision medicine, transforming care delivery, improving patient experience, and digitalizing healthcare. The Company is active worldwide.

Financial summary

BRIEF: For the three months ended 31 December 2021, Siemens Healthineers AG revenues increased 31% to EUR5.07B. Net income applicable to common stockholders increased 8% to EUR466M. Revenues reflect Diagnostics segment increase of 22% to EUR1.45B, Imaging segment increase of 9% to EUR2.45B, United States segment increase of 39% to EUR1.53B, Europe, C.I.S.,Africa,Middle East (without Germany) segment increase of 28% to EUR1.43B.

Industry:

Advanced Medical Equipment & Technology (NEC)

Henkestraße 127
ERLANGEN
BAYERN 91052
DE

Income Statement

Annual
Quarterly

News

Gold price in 2024: geopolitical tensions and rate-cut expectations keep XAU/USD supported

Investors are keeping a close eye on gold as the conflict in the Middle East escalates with a possibility of a full-scale regional war in the area.

07:56, 17 April 2024

US Earnings Season : JP Morgan, Citigroup, Wells Fargo

The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.

16:03, 11 April 2024

Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues

The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.

09:22, 11 April 2024

US CPI Preview: US inflation expected to grind lower amid fears about sticky prices

US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).

15:11, 9 April 2024